Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
Keywords:
Nivolumab
Ipilimumab
Programmed death ligand 1 (PD-L1)
Inflammatory gene expression signatures
Hepatocellular carcinoma
Note:
This is an open access article under the CC BY-NC-ND license
Citation:
Sangro-Gómez-Acebo, B. (Bruno Carlos); Melero-Bermejo, I. (Ignacio Javier); Wadhawan, S.; et al. "Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma". Journal of Hepatology. 73 (6), 2020, 1460 - 1469
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.